Home/Filings/4/0001447028-23-000040
4//SEC Filing

Meyers James R 4

Accession 0001447028-23-000040

CIK 0001447028other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 4:06 PM ET

Size

329.1 KB

Accession

0001447028-23-000040

Insider Transaction Report

Form 4
Period: 2023-05-24
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-24+55,00055,000 total
    Exercise: $2.56From: 2023-05-24Exp: 2033-05-24Common Shares (55,000 underlying)
Footnotes (2)
  • [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 24, 2023, the date of the grant.
  • [F2]The option is fully vested and exercisable as of the date of the grant.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001387521

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:06 PM ET
Size
329.1 KB